You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

CIQ Recommendations

Recommendations from CIQ

The Comité sur l'immunisation du Québec (CIQ) preferentially recommends SHINGRIX for adults 50 years of age and older. 1*

Refer to the SHINGRIX recommendations in the PIQ (Quebec Immunization Protocol) for more information.

* Reproduction of information from the PIQ, 7th ed. Zona-SU section; http://www.msss.gouv.qc.ca/professionnels/vaccination/piq-vaccins/zona-su-vaccin-sous-unitaire-contre-le-zona/

The original French version of this information was published in 2018 by the Department of Health and Social Services. The Dept. declines any responsibility for any damage, loss or injury that may result from this translation into English. In case of contradiction between the English and French versions of this information, the latter it will prevail. The Government of Quebec is and remains the only copyright owner of the work in French. The English version has not been validated by the Ministry of Health and Social Services.

Reference:

  1. Zona-SU : vaccin sous unitaire contre le zona. Ministère de la Santé et Services sociaux Québec. https://www.msss.gouv.qc.ca/professionnels/vaccination/piq-vaccins/zona-su-vaccin-sous-unitaire-contre-le-zona/. Updated September 27, 2018. Accessed October 15, 2018.